Created at	Source	Raw Value	Validated value
Nov. 26, 2021, 10:30 p.m.	oms	To evaluate the efficacy of Molnupiravir Capsule compared to standard of care in confirmed RT-PCR positive patients with mild Coronavirus Disease of 2019 (COVID-19).Timepoint: -Rate of hospitalization from randomization up to Day 14	To evaluate the efficacy of Molnupiravir Capsule compared to standard of care in confirmed RT-PCR positive patients with mild Coronavirus Disease of 2019 (COVID-19).Timepoint: -Rate of hospitalization from randomization up to Day 14
Nov. 13, 2021, 5:33 p.m.	oms	N/A	N/A
Sept. 8, 2021, 1:30 a.m.	oms	To evaluate the efficacy of Molnupiravir Capsule compared to standard of care in confirmed RT-PCR positive patients with mild Coronavirus Disease of 2019 (COVID-19).Timepoint: -Rate of hospitalization from randomization up to Day 14	To evaluate the efficacy of Molnupiravir Capsule compared to standard of care in confirmed RT-PCR positive patients with mild Coronavirus Disease of 2019 (COVID-19).Timepoint: -Rate of hospitalization from randomization up to Day 14